162 related articles for article (PubMed ID: 19383853)
1. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy.
Su DM; Zhang Q; Wang X; He P; Zhu YJ; Zhao J; Rennert OM; Su YA
Mol Cancer Ther; 2009 May; 8(5):1292-304. PubMed ID: 19383853
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism underlying differential apoptosis between human melanoma cell lines UACC903 and UACC903(+6) revealed by mitochondria-focused cDNA microarrays.
Zhang Q; Wu J; Nguyen A; Wang BD; He P; Laurent GS; Rennert OM; Su YA
Apoptosis; 2008 Aug; 13(8):993-1004. PubMed ID: 18563568
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.
Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI
Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911
[TBL] [Abstract][Full Text] [Related]
4. Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expression.
Bai X; Wu J; Zhang Q; Alesci S; Manoli I; Blackman MR; Chrousos GP; Goldstein AL; Rennert OM; Su YA
Biotechniques; 2007 Mar; 42(3):365-75. PubMed ID: 17390543
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.
Ryu B; Kim DS; Deluca AM; Alani RM
PLoS One; 2007 Jul; 2(7):e594. PubMed ID: 17611626
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.
Jourdan M; Reme T; Goldschmidt H; Fiol G; Pantesco V; De Vos J; Rossi JF; Hose D; Klein B
Br J Haematol; 2009 Apr; 145(1):45-58. PubMed ID: 19183193
[TBL] [Abstract][Full Text] [Related]
7. Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
Mirmohammadsadegh A; Baer A; Nambiar S; Bardenheuer W; Hengge UR
Cells Tissues Organs; 2004; 177(3):119-23. PubMed ID: 15388985
[TBL] [Abstract][Full Text] [Related]
8. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated mitochondrial genes and networks with drug targets in postmortem brain of patients with posttraumatic stress disorder (PTSD) revealed by human mitochondria-focused cDNA microarrays.
Su YA; Wu J; Zhang L; Zhang Q; Su DM; He P; Wang BD; Li H; Webster MJ; ; Rennert OM; Ursano RJ
Int J Biol Sci; 2008 Aug; 4(4):223-35. PubMed ID: 18690294
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells.
Cheng SL; Huang Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
Biol Pharm Bull; 2006 Apr; 29(4):655-69. PubMed ID: 16595896
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
12. Global analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanoma.
Estler M; Boskovic G; Denvir J; Miles S; Primerano DA; Niles RM
BMC Genomics; 2008 Oct; 9():478. PubMed ID: 18847503
[TBL] [Abstract][Full Text] [Related]
13. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
Leaman DW; Chawla-Sarkar M; Jacobs B; Vyas K; Sun Y; Ozdemir A; Yi T; Williams BR; Borden EC
J Interferon Cytokine Res; 2003 Dec; 23(12):745-56. PubMed ID: 14769151
[TBL] [Abstract][Full Text] [Related]
14. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of liver metastases from uveal melanoma.
Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.
Gao Z; Shang Q; Liu Z; Deng C; Guo C
Oncotarget; 2015 Nov; 6(34):36338-53. PubMed ID: 26462148
[TBL] [Abstract][Full Text] [Related]
17. Novel genes associated with malignant melanoma but not benign melanocytic lesions.
Talantov D; Mazumder A; Yu JX; Briggs T; Jiang Y; Backus J; Atkins D; Wang Y
Clin Cancer Res; 2005 Oct; 11(20):7234-42. PubMed ID: 16243793
[TBL] [Abstract][Full Text] [Related]
18. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
19. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.
Petry IB; Fieber E; Schmidt M; Gehrmann M; Gebhard S; Hermes M; Schormann W; Selinski S; Freis E; Schwender H; Brulport M; Ickstadt K; Rahnenführer J; Maccoux L; West J; Kölbl H; Schuler M; Hengstler JG
Clin Cancer Res; 2010 Jan; 16(2):451-60. PubMed ID: 20068093
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
